-madlin
Drugs that block MDM2, freeing the p53 tumour suppressor.
- Drugs ending in -madlin: 5
- Approved somewhere: 0
- With a US drug page: 0
- Stem
- -madlin
- Class
- Drugs that block MDM2, freeing the p53 tumour suppressor
- Most common targets
- MDM2, TP53 (3)
Approved and clinical-stage drugs in ChEMBL whose names ending in -madlin, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Brigimadlin | Phase 3 | — | — |
| Alrizomadlin | Phase 2 | MDM2, TP53 | Tumour suppressor p53/oncoprotein Mdm2 inhibitor |
| Navtemadlin | Phase 2 | MDM2, TP53 | Tumour suppressor p53/oncoprotein Mdm2 inhibitor |
| Siremadlin | Phase 2 | MDM2, TP53 | Tumour suppressor p53/oncoprotein Mdm2 inhibitor |
| Sulanemadlin | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO